Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Join Prof. Ben Freedman and Prof. Lis Neubeck.
Free for everyone.
After watching this webinar, participants will be able to:
At least 1/3 ischaemic strokes occur as a result of atrial fibrillation (AF). Early detection of AF and appropriate management can reduce the risk of stroke by 2/3. At least 40% of AF is asymptomatic, so case-finding in those at greatest risk of stroke has been shown to be cost-effective, readily acceptable and scalable. This webinar will focus on contemporary tools to diagnose AF.
Need assessment and educational expected outcome
People living with AF face a range of challenges both in understanding and accessing effective care. Even when the care provided is optimal, low adherence can increase the risk of complications. This webinar will complement and enhance the previous webinars by helping health professionals to understand and address patient engagement.
Prof. Ben Freedman, OAM,FRACP, FCSANZ, FAHA, FACC, FESCHeart Research Institute and University of SydneySydney, Australia
Professor Lis Neubeck, FESCSchool of Health and Social Care, SighthillEdinburgh, United Kingdom
This webinar addresses nurses, allied professions, cardiologists in training, general practitioners, and those who express an interest in atrial fibrillation, wishing to update their scientific knowledge on the topic.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live event, you must allow pop-up windows on your device.
A high-speed Internet connection is required (minimum 2 Mbps).
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903, Sophia Antipolis, FR
This programme is supported by Bristol-Myers Squibb and Pfizer Alliance in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsors.
Our mission: To reduce the burden of cardiovascular disease.
© 2019 European Society of Cardiology. All rights reserved.